European Archives - Page 308 of 1176 - European Medical Journal

Sugary Beverage Consumption During Pregnancy Linked with Adverse Outcomes

New study found a strong association between the consumption of sugary and sweetened beverages during pregnancy and adverse health outcomes for both mothers and their babies

COVID-19 Infection Does Not Affect Pregnancy Outcomes in Frozen Embryo Transfers

A study investigated whether COVID-19 infections influence embryo implantation and early development in patients undergoing frozen embryo transfer.

Western Diet May Heighten Inflammatory Bowel Disease and Colon Cancer Risk

New research reveals the impact of diet on the composition and function of our gut microbiome.

COVID-19 Linked to Accelerated Type 1 Diabetes Onset in Presymptomatic Youth

COVID-19 infection has been associated with a rapid progression to clinical type 1 diabetes in young individuals with presymptomatic disease, according to a recent study.

Multiple Myeloma Therapy Outcome Predicted Using Simple Blood Test

Study shows that monitoring absolute lymphocyte count after BCMA CAR-T therapy in relapsed or refractory multiple myeloma can predict treatment outcomes.

Long-Term Lung Damage Persists in Over 90% of COVID-19 Patients

A new study found that 92% of patients hospitalised for COVID-19 still have lung lesions two years after discharge.

Prevalence of Overactive Bladder Increases by Twenty-Eight Percent

Overactive bladder prevalence has increased by 28% in men according to a new study.

Morning Caffeine Linked to Improved Athletic Performance

A recent study investigates the effects of caffeine doses (3 mg/kg vs. 6 mg/kg) taken at different times of day on female athletes’ high-intensity performance.

AI Accurately Predicts Lung Function from Chest X-Rays

A study revealed that an AI model can accurately predict lung function metrics such as forced vital capacity and forced expiratory volume in 1 second from chest X-rays.

Semaglutide Reduces Tobacco Use in Patients with Type 2 Diabetes

New research suggests semaglutide, a medication for type 2 diabetes and obesity, may help reduce tobacco use disorder risks.